Zobrazeno 1 - 10
of 22
pro vyhledávání: '"O. Bilchenko"'
Autor:
O. Chub, O. Bilchenko, Y. Samburg, O. Godlevska, O. Vlasenko, T. Magdalits, K. Smolianyk, I. Teslenko
Publikováno v:
Kidney International Reports, Vol 6, Iss 4, Pp S106-S107 (2021)
Externí odkaz:
https://doaj.org/article/e144cd0da9cf4707b746c3ed2b285d5f
Autor:
О. Chub, O. Bilchenko
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 2(50) (2016)
The aim of the study is to determine the prevalence of plasmid-mediated resistance genes among uro- pathogens from hospitalized patients with chronic pyelonephritis. Methods. A cross-sectional study of 105patients with chronic pyelonephritis and d
Externí odkaz:
https://doaj.org/article/a57d5d323e964645b7a4b9bb74d6f496
Autor:
Anton O. Bilchenko, Olga V. Gritsenko, Volodymir O. Kolisnyk, Oleg I. Rafalyuk, Andrii V. Pyzhevskii, Yaroslav V. Myzak, Dmytro I. Besh, Victor M. Salo, Sergii O. Chaichuk, Mykhailo O. Lehoida, Ihor V. Danylchuk, Ihor V. Polivenok
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundData on the results and management strategies in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) in the Low and Lower-Middle Income Countries (LLMICs) are limited. This lack of understanding of the situat
Externí odkaz:
https://doaj.org/article/de56d03a77a14ef2900c0a3e6f5070e9
Autor:
Iryna R. Vyshnevska, Olga V. Petyunina, Mykola P. Kopytsya, Anton O. Bilchenko, Larysa L. Peteneva
Publikováno v:
Polski Merkuriusz Lekarski. 51:21-29
Aim of our study was to determine the role of the clinical and biochemical markers in predicting the outcomes at one year in patients with STEMI who have undergone primary PCI. Materials and methods: The study included 165 patients admitted with STEM
Publikováno v:
Pathologia. 19:128-134
The aim of this review was to analyse the scientific literature data on matrix metallopeptidase 9 and to analyse the available information on its prognostic value as a marker of negative outcome in the short- and long-term prognosis in patients with
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Introduction Heart failure with preserved left ventricular ejection fraction (HFpLVEF) has become the dominant form of heart failure worldwide, along with an aging population and an increasing p
Autor:
A. O. Bilchenko
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 5:82-89
The purpose of the study was to assess the impact of antihypertensive therapy depending on the classes of drugs on the level of new biomarkers of inflammation: GDF-15, P-selectin and Galectin-3 in blood plasma in patients with hypertension in combina
Autor:
A. O. Bilchenko
Publikováno v:
Problems of Uninterrupted Medical Training and Science. 2019:63-66
Autor:
A. O. Bilchenko
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 4:119-124
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: None. Introduction. Recent randomized controlled trials have shown that in heart failure (HF) patients with reduced left ventricle ejection fraction (HFrEF) atrial fibrillation (AF) ablation reduces h